News about Drug Discovery & Development

Concept Life Sciences Unveils Major Expansion of UK Drug Discovery Facilities

Concept Life Sciences, a multi-disciplined contract research organisation, has officially opened its newly expanded integrated drug discovery facilities at its Chapel-en-le-Frith headquarters, establishing one of the UK’s largest drug discovery research sites.

Drug Discovery & Development | 30/09/2025 | By Darshana |  219

Akums Highlights Lacosamide's Versatility in Epilepsy Management

Akums Drugs & Pharmaceuticals reaffirmed lacosamide, a well-established antiepileptic drug (AED), as a versatile and effective option for patients with epilepsy across age groups and clinical settings.

Drug Discovery & Development | 22/09/2025 | By Dineshwori |  203

Orforglipron by Lily Shows Significant Weight Loss and Cardiometabolic Gains in ATTAIN-1 Results

Orforglipron by Eli Lily demonstrated significant improvements across key cardiometabolic risk factors, supporting its potential as a treatment option for millions living with obesity.

Drug Discovery & Development | 18/09/2025 | By Dineshwori |  415

CDSCO Clarifies Regulatory Pathway: Cocrystals of Approved Drugs to Be Treated as New Drugs

The Central Drugs Standard Control Organisation (CDSCO) has issued a clarification stating that cocrystals of already approved active substances will be treated as new drugs under Indian regulations.

Drug Discovery & Development | 17/09/2025 | By Darshana |  352

Roche Pharma India Expands AIR Initiative to Boost Clinical Trial Capacity

Roche Pharma India has successfully completed the first phase of its Advanced Inclusive Research (AIR) Site Alliance programme. The initiative engaged 10 leading government hospitals across the country and trained nearly 400 professionals—including investigators, ethics committee members, and support staff—in global Good Clinical Practice standard.

Drug Discovery & Development | 16/09/2025 | By Darshana |  267

Monte Rosa Therapeutics Partners with Novartis on Degraders for Immune Diseases

Monte Rosa to receive an upfront payment of USD 120 million, plus option maintenance payments, and is eligible for option exercise payments and development, regulatory and sales milestones, as well as tiered royalties on global net sales.

Drug Discovery & Development | 16/09/2025 | By Dineshwori |  348

ANVISA Approves Concept Medical's MagicTouch SCB for CAD in Brazil

The approval enables commercial sales in Brazil, strengthening Concept Medical’s global footprint and advancing its mission to deliver safer and more effective treatment alternatives. The company is also undergoing ANVISA’s approval process for its wider DCB and DES portfolio, building on its robust clinical trial foundation.

Drug Discovery & Development | 16/09/2025 | By Dineshwori |  331

Novartis Enters USD 5.7 Billion Licensing Deal with Monte Rosa Therapeutics Targeting Immune Diseases

Novartis has entered into a licensing agreement with Monte Rosa Therapeutics valued at up to 5.7 billion USD. The deal centres on developing medicines for immune-mediated diseases, where the immune system mistakenly attacks healthy tissue.

Drug Discovery & Development | 15/09/2025 | By Darshana |  316

Fermenta Biotech Secures Indian Patent for Plant-Based Vitamin D3 Invention

Fermenta Biotech has been granted a patent by the Indian Patent Office for its proprietary process to produce plant-based Vitamin D3.

Drug Discovery & Development | 12/09/2025 | By Dineshwori |  472

Merck's Capvaxive Shows Strong Phase 3 Results in Children and Adolescents at High Risk of Pneumococcal Disease

Merck, known as MSD outside the United States and Canada, has reported positive results from its Phase 3 STRIDE-13 trial evaluating Capvaxive, its 21-valent pneumococcal conjugate vaccine.

Drug Discovery & Development | 12/09/2025 | By Darshana |  229